Disciplined Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,778
Closed -$275K 147
2026
Q1
$275K Buy
+9,778
New +$260K 0.1% 116
2023
Q4
Sell
-6,662
Closed -$221K 113
2023
Q3
$221K Sell
6,662
-235
-3% -$8.31K 0.13% 100
2023
Q2
$253K Sell
6,897
-952
-12% -$37.1K 0.14% 102
2023
Q1
$320K Buy
7,849
+5,982
+320% +$258K 0.13% 110
2022
Q4
$95.7K Sell
1,867
-6,231
-77% -$299K 0.05% 146
2022
Q3
$354K Sell
8,098
-60
-0.7% -$2.92K 0.16% 100
2022
Q2
$428K Buy
8,158
+1,126
+16% +$57.4K 0.19% 87
2022
Q1
$364K Buy
7,032
+99
+1% +$5.14K 0.15% 101
2021
Q4
$409K Buy
6,933
+232
+3% +$11.5K 0.18% 88
2021
Q3
$288K Buy
6,701
+3
+0% +$133 0.14% 100
2021
Q2
$262K Buy
6,698
+33
+0.5% +$1.28K 0.13% 105
2021
Q1
$241K Buy
6,665
+6,044
+973% +$215K 0.14% 101
2020
Q4
$23K Sell
621
-30
-5% -$1.1K 0.02% 191
2020
Q3
$23K Sell
651
-563
-46% -$19.7K 0.02% 206
2020
Q2
$38K Buy
1,214
+4
+0.3% +$136 0.03% 184
2020
Q1
$37K Buy
1,210
+366
+43% +$12.5K 0.04% 178
2019
Q4
$31K Buy
+844
New +$30.1K 0.03% 201

Other funds holding PFE

Disciplined Investments's PFE Position: Q2 2026 in Review

Disciplined Investments sold out of Pfizer (PFE) in Q2 2026, closing a stake of 9,778 shares — an estimated $275K sold.

Disciplined Investments first reported a position in PFE in Q4 2019 and held it in 17 quarters. The position peaked at $428K in Q2 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Disciplined Investments reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Disciplined Investments sold 9,778 Pfizer shares in Q2 2026, an estimated $275K.
  • Disciplined Investments first reported a position in Pfizer in Q4 2019 and held it in 17 quarters.
  • Disciplined Investments's Pfizer position peaked at $428K in Q2 2022.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Disciplined Investments's 13F filing for Q2 2026, filed 7 Aug 2026.